198 related articles for article (PubMed ID: 30793176)
1. Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities.
Higo H; Kubo T; Makimoto S; Makimoto G; Ihara H; Masaoka Y; Ninomiya T; Ichihara E; Ohashi K; Sato A; Hotta K; Tabata M; Takigawa N; Maeda Y; Kiura K
Jpn J Clin Oncol; 2019 May; 49(5):458-464. PubMed ID: 30793176
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
Kobayashi H; Wakuda K; Naito T; Mamesaya N; Omori S; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Gon Y; Takahashi T
Radiat Oncol; 2021 Mar; 16(1):52. PubMed ID: 33731123
[TBL] [Abstract][Full Text] [Related]
3. Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
Jeong WG; Kim YH; Ahn SJ; Jeong JU; Lee BC; Cho IJ; Kim YH
Anticancer Res; 2023 Apr; 43(4):1797-1807. PubMed ID: 36974810
[TBL] [Abstract][Full Text] [Related]
4. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
[TBL] [Abstract][Full Text] [Related]
5. Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.
Ozawa Y; Abe T; Omae M; Matsui T; Kato M; Hasegawa H; Enomoto Y; Ishihara T; Inui N; Yamada K; Yokomura K; Suda T
PLoS One; 2015; 10(10):e0140437. PubMed ID: 26460792
[TBL] [Abstract][Full Text] [Related]
6. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
8. Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer.
Petranovic M; McDermott S; Mercaldo S; Little BP; Graur A; Huang K; Fintelmann FJ; Digumarthy SR; Gainor JF
Clin Lung Cancer; 2023 Dec; 24(8):682-688.e5. PubMed ID: 37758549
[TBL] [Abstract][Full Text] [Related]
9. Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement.
Kadoch M; Kitich A; Alqalyoobi S; Lafond E; Foster E; Juarez M; Mendez C; Smith TW; Wong G; Boyd WD; Southard J; Oldham JM
Respir Med; 2018 Apr; 137():55-60. PubMed ID: 29605213
[TBL] [Abstract][Full Text] [Related]
10. Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.
Lee YH; Kim YS; Lee SN; Lee HC; Oh SJ; Kim SJ; Kim YK; Han DH; Yoo IeR; Kang JH; Hong SH
Cancer Res Treat; 2015 Oct; 47(4):676-86. PubMed ID: 25687856
[TBL] [Abstract][Full Text] [Related]
11. Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
Inoue H; Ono A; Kawabata T; Mamesaya N; Kawamura T; Kobayashi H; Omori S; Wakuda K; Kenmotsu H; Naito T; Murakami H; Yasui K; Ogawa H; Onoe T; Endo M; Harada H; Takahashi T
Invest New Drugs; 2020 Oct; 38(5):1612-1617. PubMed ID: 32128667
[TBL] [Abstract][Full Text] [Related]
12. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
[TBL] [Abstract][Full Text] [Related]
13. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
Salisbury ML; Hewlett JC; Ding G; Markin CR; Douglas K; Mason W; Guttentag A; Phillips JA; Cogan JD; Reiss S; Mitchell DB; Wu P; Young LR; Lancaster LH; Loyd JE; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
Am J Respir Crit Care Med; 2020 May; 201(10):1230-1239. PubMed ID: 32011901
[No Abstract] [Full Text] [Related]
14. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
Hunninghake GM; Goldin JG; Kadoch MA; Kropski JA; Rosas IO; Wells AU; Yadav R; Lazarus HM; Abtin FG; Corte TJ; de Andrade JA; Johannson KA; Kolb MR; Lynch DA; Oldham JM; Spagnolo P; Strek ME; Tomassetti S; Washko GR; White ES;
Chest; 2022 Feb; 161(2):470-482. PubMed ID: 34197782
[TBL] [Abstract][Full Text] [Related]
15. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
Kawano-Dourado L; Doyle TJ; Bonfiglioli K; Sawamura MVY; Nakagawa RH; Arimura FE; Lee HJ; Rangel DAS; Bueno C; Carvalho CRR; Sabbag ML; Molina C; Rosas IO; Kairalla RA
Chest; 2020 Oct; 158(4):1546-1554. PubMed ID: 32428513
[TBL] [Abstract][Full Text] [Related]
16. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
17. Interstitial lung abnormalities: prognostic stratification of subtle radiological findings.
Silva M; Milanese G; Sverzellati N
Curr Opin Pulm Med; 2018 Sep; 24(5):432-439. PubMed ID: 29939864
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for severe radiation pneumonitis in lung cancer.
Makimoto T; Tsuchiya S; Hayakawa K; Saitoh R; Mori M
Jpn J Clin Oncol; 1999 Apr; 29(4):192-7. PubMed ID: 10340042
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Lung Abnormalities in Patients With Locally Advanced Esophageal Cancer: Prevalence, Risk Factors, and Clinical Implications.
Tseng SC; Hino T; Hatabu H; Park H; Sanford NN; Lin G; Nishino M; Mamon H
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):871-877. PubMed ID: 35995596
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
